Revisiting Connectivity Map from a gene co-expression network analysis.

Area of Science:

• Transcriptomics
• Systems Biology
• Pharmacogenomics

Background:

• The Connectivity Map (CMap) is widely used for drug repositioning and predicting drug side effects.
• Current CMap analyses often overlook gene regulation pathways and functional redundancy, limiting insights.
• A systems biology approach is needed to uncover these hidden factors in transcriptional profiles.

Purpose of the Study:

• To apply Weighted Gene Co-expression Network Analysis (WGCNA) to CMap data.
• To identify key biological modules and pathways influencing drug responses.
• To develop a novel framework for drug repositioning and mechanism of action (MoA) discovery.

Main Methods:

• Weighted Gene Co-expression Network Analysis (WGCNA) applied to CMap transcriptional profiles.
• Identification and characterization of co-expressed gene modules.
• Clustering of drugs based on module expression patterns.
• Disease-based module projection for novel drug identification.

Main Results:

• Seven significant co-expression modules were identified, associated with protein binding, extracellular matrix organization, and translation.
• Drugs were successfully clustered based on shared module expression, enabling MoA inference.
• A proof-of-concept demonstrated disease-based module projection for identifying potential new drugs.

Conclusions:

• WGCNA provides a powerful framework to dissect CMap data, revealing underlying biological pathways.
• This approach enhances understanding of drug mechanisms and facilitates more effective drug repositioning.
• The developed methodology offers a novel strategy for drug discovery and MoA elucidation.